Skip to main content
. 2018 Apr 1;14(1):112–126. doi: 10.5152/iao.2018.4769

Table 1c.

Other operations, corticosteroid treatment, and complications in studies with a follow-up of minimum 12 months

Publication Other operations in conjunction with BET Operations during follow-up Corticosteroids pre/postop Other instructions or medication Complications
Silvola et al., 2014 [8] No TM perforation or grommet → tympanostomy Valsalva positive at 1 month → grommet removal
1 pt unable to do Valsalva
→ revision BET
3 pt BET to contralateral side
4 pt did not improve
→ technetium scintigraphy and for 3 of them explorative tympanotomy and middle ear endoscopy (one had carotid dehiscence and received no further operations)
Nasal corticosteroid for min 1 month preoperatively and 1 month postoperatively Valsalva 2 times/day; if Valsalva negative at 1 week, Politzer maneuver → some could perform Valsalva after that NR
Schröder et al., 2015 [10] No Revision BET to 68/622 pt marked as lost to follow-up for the first operation at the time of revision Nasal corticosteroid for 6 weeks postop NR Emphysema in the parotid region (0.3%), minor bleeding, temporary increase of tinnitus, all resolved with time; insertion of balloon catheter unsuccessful in 3 pt (4 ears)
Dalchow et al., 2016 [9] Tympanoplasty to 124/342 pt before or in conjunction with BET Revision BET to 38/342 pt 250 mg prednisolone on day 1 postoperatively Cefuroxime 500 mg ×2 for 5 days postoperatively No
Xiong et al., 2016 [11] NR NR Nasal corticosteroid, minimum 6 months preoperatively NR No
Leichtle et al., 2017 [2] BET+tympanocenthesis (24 cases), tympanoplasty type I (5 cases), tympanoplasty type III (3 cases) Revision BET (2 cases) NR Instructions and motivation for Valsalva and/or Politzer at every visit Hemotympanum (7%) resolved with time, minor nasal bleeding (21%) resolved with intranasal xylometazoline

BET, balloon Eustachian tuboplasty; NR, not reported; pt, patient(s); TM, tympanic membrane